Stocks Comparison
Natural Alternatives International vs Usana Health Sciences: revenue, profit, margins and growth compared
Natural Alternatives International brought in $129.9M of revenue in fiscal 2025, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by +14.1% at Natural Alternatives International and +8.3% at Usana Health Sciences on the year before, so Natural Alternatives International grew faster. Natural Alternatives International kept -10.5% of its revenue as net profit, Usana Health Sciences 1.2%. Free cash flow was $2.3M at Natural Alternatives International and $8.5M at Usana Health Sciences.
Side by side, latest fiscal year
| NAII | USNA | |
|---|---|---|
| Fiscal year ended | FY2025 (June 30, 2025) | FY2025 (January 3, 2026) |
| Revenue | $129.9M | $925.3M |
| Revenue growth | +14.1% | +8.3% |
| Net income | -$13.6M | $10.8M |
| Net margin | -10.5% | 1.2% |
| Free cash flow | $2.3M | $8.5M |
| Free cash flow margin | 1.8% | 0.9% |
| Earnings per share (diluted) | -$2.28 | $0.58 |
| Cash | $12.3M | $158.4M |
| Debt | n/a | n/a |
| Price to earnings | n/a | 25.0 |
| Market value | $11M | $267.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #286 of 646 · Health care | #151 of 646 · Health care |
Over the years
Questions about Natural Alternatives International and Usana Health Sciences
Which is bigger by revenue, Natural Alternatives International or Usana Health Sciences?
Usana Health Sciences is bigger by revenue: $925.3M in fiscal 2025, against $129.9M for Natural Alternatives International in fiscal 2025.
Which keeps more of its revenue as profit, Natural Alternatives International or Usana Health Sciences?
Natural Alternatives International had a net margin of -10.5% in fiscal 2025; Usana Health Sciences had 1.2% in fiscal 2025.
Which grew revenue faster, Natural Alternatives International or Usana Health Sciences?
In their latest fiscal years revenue changed by +14.1% at Natural Alternatives International and +8.3% at Usana Health Sciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.